Timothy E. Corcoran

3.4k total citations
87 papers, 2.6k citations indexed

About

Timothy E. Corcoran is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Timothy E. Corcoran has authored 87 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Timothy E. Corcoran's work include Inhalation and Respiratory Drug Delivery (42 papers), Cystic Fibrosis Research Advances (26 papers) and Neonatal Respiratory Health Research (21 papers). Timothy E. Corcoran is often cited by papers focused on Inhalation and Respiratory Drug Delivery (42 papers), Cystic Fibrosis Research Advances (26 papers) and Neonatal Respiratory Health Research (21 papers). Timothy E. Corcoran collaborates with scholars based in United States, Canada and Australia. Timothy E. Corcoran's co-authors include Norman Chigier, Aldo Iacono, Bill T. Ameredes, Timothy B. Oriss, Barbara Dixon‐McCarthy, Marina Ostroukhova, Anuradha Ray, Liyan Yang, Carole Seguin‐Devaux and Kenneth R. McCurry and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Timothy E. Corcoran

87 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy E. Corcoran United States 29 1.4k 536 498 370 293 87 2.6k
Pieter Zanen Netherlands 39 3.0k 2.2× 339 0.6× 1.4k 2.7× 207 0.6× 33 0.1× 126 4.1k
Alexander Bachmann Switzerland 45 5.4k 4.0× 1.3k 2.5× 111 0.2× 263 0.7× 126 0.4× 231 9.1k
H. Furukawa Japan 22 129 0.1× 840 1.6× 83 0.2× 151 0.4× 264 0.9× 141 2.0k
P. Diot France 35 3.2k 2.4× 313 0.6× 984 2.0× 271 0.7× 13 0.0× 173 4.5k
Y. Bertrand France 30 149 0.1× 197 0.4× 512 1.0× 305 0.8× 63 0.2× 114 2.8k
Richard A. Hopkins United States 34 803 0.6× 1.8k 3.4× 81 0.2× 333 0.9× 16 0.1× 160 4.0k
Martin Stockmann Germany 33 246 0.2× 1.1k 2.1× 177 0.4× 56 0.2× 223 0.8× 153 3.0k
George M. Williams United States 34 1.3k 1.0× 1.6k 3.0× 48 0.1× 211 0.6× 352 1.2× 151 3.4k
Joachim Richter Germany 21 1.1k 0.8× 449 0.8× 248 0.5× 65 0.2× 18 0.1× 50 1.7k
John F. Madden United States 37 1.3k 1.0× 1.3k 2.4× 189 0.4× 261 0.7× 28 0.1× 126 4.5k

Countries citing papers authored by Timothy E. Corcoran

Since Specialization
Citations

This map shows the geographic impact of Timothy E. Corcoran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy E. Corcoran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy E. Corcoran more than expected).

Fields of papers citing papers by Timothy E. Corcoran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy E. Corcoran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy E. Corcoran. The network helps show where Timothy E. Corcoran may publish in the future.

Co-authorship network of co-authors of Timothy E. Corcoran

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy E. Corcoran. A scholar is included among the top collaborators of Timothy E. Corcoran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy E. Corcoran. Timothy E. Corcoran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Darquenne, Chantal, et al.. (2024). The effects of airway disease on the deposition of inhaled drugs. Expert Opinion on Drug Delivery. 21(8). 1175–1190. 6 indexed citations
2.
Donaldson, Scott H., Timothy E. Corcoran, Joseph M. Pilewski, et al.. (2023). Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis. Journal of Cystic Fibrosis. 23(1). 155–160. 14 indexed citations
3.
Corcoran, Timothy E., Carol A. Bertrand, Michael M. Myerburg, et al.. (2022). Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic response. ERJ Open Research. 8(4). 382–2022. 1 indexed citations
4.
Kothari, Sagar, et al.. (2022). Preclinical Studies of the Nebulized Delivery of Liposomal Amphotericin B. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(6). 307–312. 2 indexed citations
5.
Freiser, Monika E., et al.. (2021). Aerosol and Droplet Risk of Common Otolaryngology Clinic Procedures. Annals of Otology Rhinology & Laryngology. 130(11). 1245–1253. 1 indexed citations
6.
Sembrat, John, Amy Z. Stetten, Robert D. Tilton, et al.. (2021). Effect of a Surfactant Additive on Drug Transport and Distribution Uniformity After Aerosol Delivery to Ex Vivo Lungs. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(3). 146–153. 1 indexed citations
7.
Corcoran, Timothy E.. (2021). Measurements of deposited aerosol dose in infants and small children. Annals of Translational Medicine. 9(7). 595–595. 11 indexed citations
8.
Donaldson, Scott H., Beth L. Laube, Peter J. Mogayzel, et al.. (2021). Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study. Journal of Cystic Fibrosis. 21(1). 143–145. 16 indexed citations
9.
Freiser, Monika E., et al.. (2020). Novel Use of Vitamin B2 as a Fluorescent Tracer in Aerosol and Droplet Contamination Models in Otolaryngology. Annals of Otology Rhinology & Laryngology. 130(3). 280–285. 7 indexed citations
10.
Fink, James B., Stéphan Ehrmann, Jie Li, et al.. (2020). Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 33(6). 300–304. 77 indexed citations
11.
Corcoran, Timothy E., Phillip S. Adams, Yuliya Domnina, et al.. (2019). Deposition studies of aerosol delivery by nasal cannula to infants. Pediatric Pulmonology. 54(8). 1319–1325. 28 indexed citations
12.
Corcoran, Timothy E., Alex S. Huber, Michael M. Myerburg, et al.. (2019). Multiprobe Nuclear Imaging of the Cystic Fibrosis Lung as a Biomarker of Therapeutic Effect. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(4). 242–249. 4 indexed citations
13.
Corcoran, Timothy E., Jennifer L. Goralski, Landon W. Locke, et al.. (2017). Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis. Pediatric Pulmonology. 52(9). 1142–1149. 13 indexed citations
14.
Stetten, Amy Z., et al.. (2017). Aerosolizing Lipid Dispersions Enables Antibiotic Transport Across Mimics of the Lung Airway Surface Even in the Presence of Pre-existing Lipid Monolayers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(4). 212–220. 10 indexed citations
15.
Locke, Landon W., Michael M. Myerburg, Daniel J. Weiner, et al.. (2016). Pseudomonasinfection and mucociliary and absorptive clearance in the cystic fibrosis lung. European Respiratory Journal. 47(5). 1392–1401. 20 indexed citations
16.
Corcoran, Timothy E., et al.. (2015). Surfactant Driven Post-Deposition Spreading of Aerosols on Complex Aqueous Subphases. 2: Low Deposition Flux Representative of Aerosol Delivery to Small Airways. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(5). 394–405. 8 indexed citations
17.
Garoff, Stephen, et al.. (2008). Postdeposition Dispersion of Aerosol Medications Using Surfactant Carriers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21(4). 361–370. 20 indexed citations
18.
Kim, In K., et al.. (2006). Heliox-Driven Albuterol Nebulization for Asthma Exacerbations: An Overview. Respiratory Care. 51(6). 613–618. 37 indexed citations
19.
Corcoran, Timothy E., R. Venkataramanan, Barry McCook, et al.. (2006). Aerosol Deposition of Lipid Complex Amphotericin-B (Abelcet) in Lung Transplant Recipients. American Journal of Transplantation. 6(11). 2765–2773. 49 indexed citations
20.
Ostroukhova, Marina, Carole Seguin‐Devaux, Timothy B. Oriss, et al.. (2004). Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3. Journal of Clinical Investigation. 114(1). 28–38. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieter Zanen Breakdown of academic impact, for papers by Alexander Bachmann Breakdown of academic impact, for papers by H. Furukawa Breakdown of academic impact, for papers by P. Diot Breakdown of academic impact, for papers by Y. Bertrand Breakdown of academic impact, for papers by Richard A. Hopkins Breakdown of academic impact, for papers by Martin Stockmann Breakdown of academic impact, for papers by George M. Williams Breakdown of academic impact, for papers by Joachim Richter Breakdown of academic impact, for papers by John F. Madden
Rankless by CCL
2026